Simplex

<!-- Name:DistributionId Value:8798511 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

A collaboration between Ghent University in Belgium and Cleveland Clinic's Florida Research & Innovation Center (FRIC) found a new way genetics influences the body's antiviral response by studying a life-threatening disease caused by a…

A new study by researchers at University of Illinois Chicago suggests that when the protein optineurin, or OPTN, is present in cells it restricts the spread of HSV-1, the herpes simplex virus type 1. In a "first of its kind" study,…

- IM-250 reduces viral load, viral shedding and recurrence rate - Potential treatment for persistent, neurotrophic herpes simplex Munich, Germany, June 16, 2021 - Innovative Molecules GmbH, a drug development company focused on…